Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Autor: van Vollenhoven, RF a, b, *, Ernestam, S a, Geborek, P d, Petersson, IF d, e, Cöster, L f, Waltbrand, E g, Zickert, A c, Theander, J h, Thörner, Å i, Hellström, H j, Teleman, A k, Dackhammar, C l, Akre, F m, Forslind, K d, n, Ljung, L o, Oding, R p, Chatzidionysiou, A a, Wörnert, M a, Bratt, J a
Zdroj: In The Lancet 8-14 August 2009 374(9688):459-466
Databáze: ScienceDirect